EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib-Reference-Cited by-同舟云学术

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib

Published:2007-06 Issue:3 Volume:56 Page:445-448
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Soh Junichi,Toyooka Shinichi,Ichihara Shuji,Suehisa Hiroshi,Kobayashi Naruyuki,Ito Sachio,Yamane Masaomi,Aoe Motoi,Sano Yoshifumi,Kiura Katsuyuki,Date Hiroshi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993

2. The role of EGFR inhibitors in nonsmall cell lung cancer;Ciardiello;Curr Opin Oncol,2004

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci USA,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel lignans from Zanthoxylum nitidum and antiproliferation activity of sesaminone in osimertinib-resistant non-small cell lung cancer cells;Bioorganic Chemistry;2023-05

2. Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system;Cytojournal;2022-02-04

3. Nitidumpeptins A and B, Cyclohexapeptides Isolated from Zanthoxylum nitidum var. tomentosum: Structural Elucidation, Total Synthesis, and Antiproliferative Activity in Cancer Cells;The Journal of Organic Chemistry;2021-01-07

4. Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies;Cells;2020-08-07

5. Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers;Cells;2019-11-18